brintellex
ValprolBanner
Annals of Indian Academy of Neurology
  Users Online: 3163 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
REVIEW ARTICLE
Year : 2007  |  Volume : 10  |  Issue : 4  |  Page : 214-224

Limb girdle muscular dystrophies: The clinicopathological viewpoint


1 Assistance Publique - Hopitaux de Paris, Hopital Marin, BP40139, 64700 Hendaye, France
2 Assistance-Publique - Hopitaux de Paris, Hospital Cochin-Maternités, Boulevard de Port Royal, 75014 Paris, France

Correspondence Address:
J Andoni Urtizberea
Assistance Publique - Hopitaux de Paris, Hopital Marin, BP40139, 64700 Hendaye
France
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-2327.37813

Rights and Permissions

Limb girdle muscular dystrophies (LGMD) are characterized by involvement of the pelvic and shoulder girdles, classically with an onset in the second or third decade and a slow progression as opposed to Duchenne muscular dystrophy. In fact, there are many clinical variants that are related to this broad definition. For the past 13 years and since the discovery of calpain-3 as the underlying defect in LGMD 2A in 1995, a number of different genes have been found to cause LGMD; some of whose encoding proteins are located either in the sarcolemma, nucleus, cytosol or in the extra-cellular matrix. Very little is known regarding a possible common pathogenesis between all these entities. The current nomenclature of LGMDs, although a bit confusing, is still necessary to continue the establishment of homogeneous cohorts of patients and to look for unknown genes. The diagnosis of LGMD is nowadays based on a complementary clinical, immunocytochemical and genetic approach that is best achieved in specialized myology centers. In this context, India can make a significant contribution to improve the routine diagnosis in LGMD patients and to find new LGMD genes in genetic isolates. Therapeutic prospects in LGMD, although quite exciting, remain at a preliminary stage, especially those with gene-therapy orientation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed10367    
    Printed160    
    Emailed0    
    PDF Downloaded525    
    Comments [Add]    
    Cited by others 1    

Recommend this journal